EBMT 2018 | Endothelial dysfunction in transplant: defibrotide for VOD

Paul Richardson

Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks about the pooled analysis of the efficacy of defibrotide in adults with veno-occlusive disease (VOD).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter